Format

Send to

Choose Destination
See comment in PubMed Commons below
Diagn Microbiol Infect Dis. 2006 Nov;56(3):341-4. Epub 2006 Oct 17.

Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.

Author information

1
Infection Discovery Department, AstraZeneca, SK10 4TG Macclesfield, Cheshire, UK. philip.turner@astrazeneca.com

Abstract

This article examines the activity of meropenem and imipenem against Pseudomonas aeruginosa isolates from the Meropenem Yearly Susceptibility Test Information Collection program between 1997 and 2005. In particular, it examines the activity of meropenem against imipenem-resistant strains and vice versa. Meropenem proved to be active against up to a 3rd of imipenem-resistant strains.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center